Monophasic Estrogen-progestogen Therapy and Sexuality in Postmenopausal Women

Overview

Journal Clin Drug Investig

Date 2007 Jan 16

PMID 17217318

Citations 2

Authors

A M Fonseca

V R Bagnoli

S R L Penteado

J S Paixao

A L Cavalcanti

J A PINOTTI

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to evaluate the effects of monophasic estrogen-progestogen therapy on the sexuality and climacteric symptoms of postmenopausal women.

Patients And Methods: A prospective, randomised, double-blind, crossover, placebo-controlled, single-centre study was carried out over a total of 12 consecutive months in 40 postmenopausal women with an intact uterus who had no contraindications to hormone therapy. Patients received 17beta-estradiol 2mg in combination with norethisterone acetate 1mg (Cliane) daily for 6 months or one placebo tablet daily for 6 months. The tablets were identical in appearance. After 6 months, the groups were crossed over and the patients were followed up for another 6 months. The groups were homogenous with respect to age, height, bodyweight, body mass index and race. For the statistical analysis, the group receiving hormone therapy was referred to as group A and the placebo group was designated group B, irrespective of the placebo/hormone therapy sequence.

Results: In group A there were fewer hot flashes (F=22.85, p<0.01) and an improvement in sexual interest (F=5.55, p<0.05). The sequence in which the medication was received resulted in a statistically significant difference with respect to dyspareunia (F=9.65, p<0.01) and satisfaction with the duration of penetration (F=6.58, p<0.05). In the intrapatient analysis of variation with respect to orgasmic capability and the presence of dialogue with partner regarding the couple's sexual life, whether the placebo was taken prior to or following hormone therapy was significant (F=17.12, p<0.001 and F=7.10, p<0.05, respectively).

Conclusions: Monophasic estrogen-progestogen therapy has a beneficial effect on sexuality and on hot flashes in postmenopausal women.

Citing Articles

Hormone therapy for sexual function in perimenopausal and postmenopausal women.

Lara L, Cartagena-Ramos D, Figueiredo J, Rosa-E-Silva A, Ferriani R, Martins W Cochrane Database Syst Rev. 2023; 8:CD009672.

PMID: 37619252 PMC: 10449239. DOI: 10.1002/14651858.CD009672.pub3.

Dyspareunia in postmenopausal women: a critical review.

Kao A, Binik Y, Kapuscinski A, Khalife S Pain Res Manag. 2008; 13(3):243-54.

PMID: 18592062 PMC: 2671314. DOI: 10.1155/2008/269571.

References

Borissova A, Kovatcheva R, Shinkov A, Vukov M . A study of the psychological status and sexuality in middle-aged Bulgarian women: significance of the hormone replacement therapy (HRT). Maturitas. 2001; 39(2):177-83. DOI: 10.1016/s0378-5122(01)00191-8. View

SEMMENS J, Wagner G . Estrogen deprivation and vaginal function in postmenopausal women. JAMA. 1982; 248(4):445-8. View

Wiklund I, Karlberg J, Mattsson L . Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol. 1993; 168(3 Pt 1):824-30. DOI: 10.1016/s0002-9378(12)90828-5. View

Moreira Junior E, Glasser D, Dos Santos D, Gingell C . Prevalence of sexual problems and related help-seeking behaviors among mature adults in Brazil: data from the global study of sexual attitudes and behaviors. Sao Paulo Med J. 2005; 123(5):234-41. PMC: 11060369. DOI: 10.1590/s1516-31802005000500007. View

Guthrie J, Dennerstein L, Taffe J, Lehert P, Burger H . Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause. 2005; 12(4):460-7. DOI: 10.1097/01.GME.0000155200.80687.BE. View

Rust J, Golombok S . The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav. 1986; 15(2):157-65. DOI: 10.1007/BF01542223. View

Utian W . The true clincal features of postmenopause and oöphorectomy, and their response to oestrogen therapy. S Afr Med J. 1972; 46(23):732-7. View

Dennerstein L, Dudley E, Hopper J, Burger H . Sexuality, hormones and the menopausal transition. Maturitas. 1997; 26(2):83-93. DOI: 10.1016/s0378-5122(96)01093-6. View

Sarrel P . Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. Int J Impot Res. 1998; 10 Suppl 2:S91-3; discussion S98-101. View

10.

Abdo C, Oliveira Junior W, Moreira Junior E, Abdo J, Fittipaldi J . The impact of psychosocial factors on the risk of erectile dysfunction and inhibition of sexual desire in a sample of the Brazilian population. Sao Paulo Med J. 2005; 123(1):11-4. PMC: 11052450. DOI: 10.1590/s1516-31802005000100003. View

11.

Hays J, Ockene J, Brunner R, Kotchen J, Manson J, Patterson R . Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003; 348(19):1839-54. DOI: 10.1056/NEJMoa030311. View

12.

Barrett-Connor E, Young R, NOTELOVITZ M, Sullivan J, Wiita B, Yang H . A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med. 2000; 44(12):1012-20. View

13.

Penteado S, Fonseca A, Bagnoli V, Assis J, PINOTTI J . Sexuality in healthy postmenopausal women. Climacteric. 2004; 6(4):321-9. View

14.

Coope J, Thomson J, Poller L . Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J. 1975; 4(5989):139-43. PMC: 1674796. DOI: 10.1136/bmj.4.5989.139. View

15.

Nathorst-Boos J, Wiklund I, Mattsson L, Sandin K, von Schoultz B . Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand. 1993; 72(8):656-60. DOI: 10.3109/00016349309021160. View

16.

Sherwin B . The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 1991; 72(2):336-43. DOI: 10.1210/jcem-72-2-336. View

17.

Lobo R, Rosen R, Yang H, Block B, van der Hoop R . Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril. 2003; 79(6):1341-52. DOI: 10.1016/s0015-0282(03)00358-3. View

18.

Laumann E, Nicolosi A, Glasser D, Paik A, Gingell C, Moreira E . Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2004; 17(1):39-57. DOI: 10.1038/sj.ijir.3901250. View

19.

Dennerstein L, Burrows G, Hyman G, Sharpe K . Hormone therapy and affect. Maturitas. 1979; 1(4):247-59. DOI: 10.1016/0378-5122(79)90015-x. View